221.41

0.03% 0.085

Cidara Therapeutics Inc (CDTX)

Overview News Price History Option Chain Financials Discussions Forecast

Cidara Therapeutics Inc stock is traded at $221.41, with a volume of 546.29K. It is up +0.03% in the last 24 hours and up +0.47% over the past month. Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Previous Close:

$221.32

Open:

$221.32

24h Volume:

546.29K

Relative Volume:

0.41

Market Cap:

$6.96B

Revenue:

$302.00K

Net Income/Loss:

$-117.10M

P/E Ratio:

-19.89

EPS:

-11.13

Net Cash Flow:

$-129.13M

1W Performance:

+0.27%

1M Performance:

+0.47%

6M Performance:

+353.86%

1Y Performance:

+725.79%

1-Day Range:

$221.32

$221.41

1-Week Range:

$220.47

$221.42

52-Week Range:

$15.22

$221.42

Cidara Therapeutics Inc Stock (CDTX) Company Profile

Name

Cidara Therapeutics Inc

Sector

Healthcare (1126)

Industry

Biotechnology (624)

Phone

858-752-6170

Address

6310 NANCY RIDGE DRIVE, SAN DIEGO, CA

Employee

Twitter

@CidaraThera

Next Earnings Date

2024-10-31

Latest SEC Filings

CDTX's Discussions on Twitter

Compare CDTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDTX Cidara Therapeutics Inc	221.39	6.96B	302.00K	-117.10M	-129.13M	-11.13
VRTX Vertex Pharmaceuticals Inc	468.04	113.87B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	773.71	80.22B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	404.07	52.56B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	801.66	49.31B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.78	37.37B	447.02M	-1.18B	-906.14M	-6.1812

Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-17-25	Downgrade	JP Morgan	Overweight → Neutral
Nov-17-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-17-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Oct-16-25	Initiated	Morgan Stanley	Overweight
Oct-10-25	Initiated	JP Morgan	Overweight
Jun-18-25	Resumed	H.C. Wainwright	Buy
Mar-12-25	Initiated	Citizens JMP	Mkt Outperform
Jan-27-25	Resumed	Cantor Fitzgerald	Overweight
Dec-13-24	Initiated	RBC Capital Mkts	Outperform
Nov-08-24	Initiated	Guggenheim	Buy
Aug-14-24	Upgrade	H.C. Wainwright	Neutral → Buy
Dec-03-21	Resumed	H.C. Wainwright	Buy
Sep-22-21	Upgrade	WBB Securities	Buy → Strong Buy
Mar-04-21	Initiated	Aegis Capital	Buy
Sep-04-19	Upgrade	Wedbush	Neutral → Outperform
Jul-26-18	Initiated	Citigroup	Buy
Apr-21-17	Initiated	Raymond James	Strong Buy
Apr-17-17	Reiterated	H.C. Wainwright	Buy
Apr-12-17	Initiated	Ladenburg Thalmann	Buy
Apr-11-17	Resumed	Wedbush	Outperform
Feb-22-17	Reiterated	H.C. Wainwright	Buy
Feb-22-17	Upgrade	WBB Securities	Sell → Hold
Dec-21-16	Resumed	Leerink Partners	Outperform
Dec-19-16	Initiated	H.C. Wainwright	Buy
Sep-23-16	Downgrade	WBB Securities	Hold → Sell
Oct-09-15	Upgrade	WBB Securities	Sell → Hold
May-11-15	Initiated	Jefferies	Buy
May-11-15	Initiated	Leerink Partners	Outperform
May-11-15	Initiated	Needham	Buy
May-11-15	Initiated	Wedbush	Outperform
Apr-23-15	Initiated	WBB Securities	Sell

View All

Cidara Therapeutics Inc Stock (CDTX) Latest News

10:14 AM

Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat

10:14 AM

09:57 AM

RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Worcester Telegram

09:57 AM

09:45 AM

Stock Watch: Biotech Acquisitions Drive Sector Momentum Going Into 2026 - Citeline News & Insights

09:45 AM

05:49 AM

Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat

05:49 AM

Jan 05, 2026

RSI Check: Will PROV stock outperform value stocksJuly 2025 Technicals & Proven Capital Preservation Methods - moha.gov.vn

Jan 05, 2026

Cidara Therapeutics stock hits 52-week high at 221.24 USD By Investing.com - Investing.com South Africa

Jan 05, 2026

Jan 04, 2026

Merck stock in focus before Monday: Cidara deal deadline hits Jan. 6 as MRK sits near 52-week high - ts2.tech

Jan 04, 2026

How (CDTX) Movements Inform Risk Allocation Models - Stock Traders Daily

Jan 04, 2026

Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat

Jan 04, 2026

Jan 03, 2026

Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week - ts2.tech

Jan 03, 2026

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. - AOL.com

Jan 03, 2026

Cidara Therapeutics (CDTX) rockets 722% in 2025 on Merck $9.2-billion merger - MSN

Jan 03, 2026

Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? - sharewise.com

Jan 03, 2026

Jan 02, 2026

Cidara Therapeutics (CDTX) Rockets 722% in 2025 on Merck $9.2-Billion Merger - Insider Monkey

Jan 02, 2026

Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey

Jan 02, 2026

Dec 31, 2025

12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews

Dec 31, 2025

Best Biotech Stocks To Follow NowDecember 28th - MarketBeat

Dec 31, 2025

Dec 30, 2025

Biotech Stocks To ConsiderDecember 27th - MarketBeat

Dec 30, 2025

New Highs: Why Cidara Therapeutics Inc stock appeals to analystsWeekly Profit Recap & Daily Profit Focused Stock Screening - moha.gov.vn

Dec 30, 2025

Dec 29, 2025

Cidara: Merck's Acquisition Based On CD388 Flu Prevention Potential (NASDAQ:CDTX) - Seeking Alpha

Dec 29, 2025

Dec 28, 2025

Best Biotech Stocks Worth WatchingDecember 18th - MarketBeat

Dec 28, 2025

Dec 27, 2025

Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session - ts2.tech

Dec 27, 2025

Dec 24, 2025

Understanding Momentum Shifts in (CDTX) - Stock Traders Daily

Dec 24, 2025

Dec 23, 2025

Top Biotech Stocks To Add to Your WatchlistDecember 20th - MarketBeat

Dec 23, 2025

Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat

Dec 23, 2025

Dec 22, 2025

Top 10 healthcare stocks according to YTD performance, as the sector holds steady - Seeking Alpha

Dec 22, 2025

Market Review: Will Cidara Therapeutics Inc stock recover faster than marketEarnings Risk Summary & Smart Swing Trading Techniques - moha.gov.vn

Dec 22, 2025

Dec 21, 2025

What dividend safety score for Cidara Therapeutics Inc. stockMarket Capitalization Trends & Minimal Capital Appreciation - Bollywood Helpline

Dec 21, 2025

Best Biotech Stocks To Watch NowDecember 16th - MarketBeat

Dec 21, 2025

Dec 20, 2025

Energy Moves: What market sentiment indicators show for Cidara Therapeutics Inc. (20D0) stockFed Meeting & AI Powered Buy/Sell Recommendations - moha.gov.vn

Dec 20, 2025

Why Cidara Therapeutics Inc. stock attracts high net worth investors - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

Is Cidara Therapeutics Inc. stock a top momentum play2025 Valuation Update & Verified Technical Trade Signals - ulpravda.ru

Dec 19, 2025

Will Cidara Therapeutics Inc. stock reach all time highs in 2025Weekly Investment Recap & Comprehensive Market Scan Reports - Улправда

Dec 19, 2025

Merck, Cidara Therapeutics see US FTC grant early termination for $9.2bn deal - MLex

Dec 19, 2025

Merck, Cidara Therapeutics granted early termination by US FTC - MLex

Dec 19, 2025

Why Cidara Therapeutics Inc. stock appeals to analystsJuly 2025 Patterns & Expert Approved Momentum Ideas - DonanımHaber

Dec 19, 2025

What market sentiment indicators show for Cidara Therapeutics Inc. (20D0) stock2025 Momentum Check & Fast Momentum Entry Tips - Улправда

Dec 19, 2025

Dec 18, 2025

Sectors Review: Why Cidara Therapeutics Inc. stock attracts high net worth investorsQuarterly Trade Review & Weekly Setup with ROI Potential - Улправда

Dec 18, 2025

Halper Sadeh LLC Encourages EB, KPLT, WBD, CDTX Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire

Dec 18, 2025

Cidara Therapeutics (CDTX): Assessing Valuation After a 200% Three‑Month Share Price Surge - Yahoo Finance

Dec 18, 2025

Dec 13, 2025

Shane Ward Sells 9,959 Shares of Cidara Therapeutics (NASDAQ:CDTX) Stock - MarketBeat

Dec 13, 2025

(CDTX) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Dec 13, 2025